{"id":68074,"date":"2023-04-26T03:00:59","date_gmt":"2023-04-26T10:00:59","guid":{"rendered":"https:\/\/www.jamasoftware.com\/?p=68074"},"modified":"2024-01-18T00:25:46","modified_gmt":"2024-01-18T08:25:46","slug":"fda-moving-ahead-with-rulemaking-on-lab-developed-tests-without-waiting-for-congress-bioworld","status":"publish","type":"post","link":"https:\/\/www.jamasoftware.com\/legacy\/blog\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\/","title":{"rendered":"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld"},"content":{"rendered":"<p><img decoding=\"async\" class=\"aligncenter size-full wp-image-68075\" src=\"https:\/\/www.jamasoftware.com\/media\/2023\/04\/BioWorld-1.png\" alt=\"FDA\" width=\"1024\" height=\"512\" srcset=\"https:\/\/www.jamasoftware.com\/legacy\/media\/2023\/04\/BioWorld-1.png 1024w, https:\/\/www.jamasoftware.com\/legacy\/media\/2023\/04\/BioWorld-1-300x150.png 300w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p>Jama Software is always looking for news that would benefit and inform our industry partners. As such, we\u2019ve curated a series of customer and industry spotlight articles that we found insightful. In this blog post, we share an article, sourced from <a href=\"https:\/\/www.medtechdive.com\/\" target=\"_blank\" rel=\"noopener\">MedTech Dive<\/a>, titled <a href=\"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Issue:%202023-03-03%20MedTech%20Dive%20%5Bissue:48520%5D&amp;utm_term=MedTech%20Dive\" target=\"_blank\" rel=\"noopener\">\u201cFDA moving ahead with rulemaking on lab developed tests without waiting for Congress: BioWorld\u201d<\/a> \u2013 originally authored by <a href=\"https:\/\/www.medtechdive.com\/editors\/ntaylor\/\" target=\"_blank\" rel=\"noopener\">Nick Paul Taylor<\/a> and published on March 2, 2023.<\/p>\n<hr \/>\n<h2>FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld<\/h2>\n<h3>Dive Brief:<\/h3>\n<ul>\n<li>The U.S. Food and Drug Administration is \u201cmoving forward with rulemaking\u201d on laboratory developed tests (LDTs) without waiting for new powers from Congress, a senior FDA official said at an industry conference.<\/li>\n<li>Elizabeth Hillebrenner said on a panel Wednesday that the agency cannot \u201cjust stand by\u201d given the perceived public health problem created by LDTs and the failure of Congress to pass legislation.<\/li>\n<li>The FDA has yet to set a timeline for LDT rulemaking or provide a close look at its plans, Hillebrenner said, noting that the agency will follow a three-tier risk framework, but giving few other details.<\/li>\n<\/ul>\n<hr \/>\n<h4><span style=\"color: #ff6600;\"><strong>RELATED: <\/strong><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"\/blog\/practical-guide-for-implementing-software-validation-in-medical-devices-from-fda-guidance-to-real-world-application-part-i\" target=\"_blank\" rel=\"\u201cnoopener noopener\">Practical Guide for Implementing Software Validation in Medical Devices: From FDA Guidance to Real-World Application \u2013 Part I<\/a><\/span><\/span><\/h4>\n<hr \/>\n<h3>Dive Insight:<\/h3>\n<p>Lawmakers have been trying to pass LDT legislation for years. An earlier form of the Verifying Accurate Leading-Edge IVCT Development (VALID) Act was <a href=\"https:\/\/www.bennet.senate.gov\/public\/index.cfm?p=press-releases&amp;id=AED130D0-1F11-4A9F-8351-4376C7B1A26F\" target=\"_blank\" rel=\"noopener\">introduced<\/a> to Congress in 2018. Key aspects of the draft advanced as part of the FDA\u2019s user fee package last year, only to be <a href=\"https:\/\/www.medtechdive.com\/news\/senate-passes-resolution-user-fees\/633016\/\" target=\"_blank\" rel=\"noopener\">cut<\/a> from the final version. A push to pass the VALID Act as standalone law <a href=\"https:\/\/www.medtechdive.com\/news\/diagnostic-testing-reform-missing-2022-spending-bill\/639255\/\" target=\"_blank\" rel=\"noopener\">fell short<\/a> late last year.<\/p>\n<p>The FDA <a href=\"https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/laboratory-developed-tests\" target=\"_blank\" rel=\"noopener\">identified<\/a> a need to reconsider its policy of enforcement discretion for LDTs in 2010, reflecting the increasing complexity and risks of the tests, and shared a discussion paper in 2017. However, the paper is not enforceable.<\/p>\n<hr \/>\n<h4><span style=\"color: #ff6600;\"><strong>RELATED: <\/strong><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"\/blog\/2023-predictions-for-medical-device-product-development\" target=\"_blank\" rel=\"\u201cnoopener noopener\">2023 Predictions for Medical Device Product Development<\/a><\/span><\/span><\/h4>\n<hr \/>\n<p>Legislation would clarify the FDA\u2019s authority to regulate LDTs and give the agency new powers, but in the ongoing absence of action from Congress, work is now advancing under the current statutory authority. Hillebrenner, associate director for scientific and regulatory programs at the FDA\u2019s Center for Devices and Radiological Health, <a href=\"http:\/\/www.acla.com\/forms\/meeting\/Microsite\/ACLA_Annual_Meeting_2023,3\" target=\"_blank\" rel=\"noopener\">outlined<\/a> the situation at an American Clinical Laboratory Association event.<\/p>\n<p>In comments reported by <a href=\"https:\/\/www.bioworld.com\/articles\/694701-hillebrenner-says-fda-no-longer-waiting-on-congress-for-ldt-regulation?v=preview\" target=\"_blank\" rel=\"noopener\">BioWorld<\/a>, Hillebrenner noted that FDA Commissioner Robert Califf \u201chas already said all options are on the table, including rulemaking, and we are moving forward.\u201d The FDA continues to support legislation such as the VALID Act that provides a regulatory framework in line with modern diagnostics but is no longer willing to wait on Congress to address the problems posed by LDTs, she said.<\/p>\n<hr \/>\n<p><!-- Uberflip Embedded Hub Widget --><\/p>\n<div id=\"UfEmbeddedHub1680887945611\"><\/div>\n<p><script>\n  window._ufHubConfig = window._ufHubConfig || [];\n  window._ufHubConfig.push({\n    'containers':{'app':'#UfEmbeddedHub1680887945611'},\n    'collection': '4131730',\n    'openLink':function(url){\n      window.open(url);\n    },\n    'lazyloader':{\n      'itemDisplayLimit':20,\n      'maxTilesPerRow':3,\n      'maxItemsTotal': 3\n    },\n    'tileSize': 'small',\n    'enablePageTracking':false,\n    'baseUrl': 'https:\/\/resources.jamasoftware.com\/',\n    'filesUrl': 'https:\/\/resources.jamasoftware.com\/',\n    'generatedAtUTC': '2023-04-07 17:18:55',\n  });\n  <\/script><\/p>\n<p><script>(function(d,t,u) {\n    function load(){\n      var s=d.createElement(t);s.src=u;d.body.appendChild(s);\n    }\n    if (window.addEventListener) {\n      window.addEventListener('load',load,false);\n    }\n    else if (window.attachEvent) {\n      window.attachEvent('onload',load);\n    }\n    else{\n      window.onload=load;\n    }\n  }(document,'script','https:\/\/resources.jamasoftware.com\/hubsFront\/embed_collection'));\n  <\/script><br \/>\n<!-- \/End Uberflip Embedded Hub Widget --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jama Software is always looking for news that would benefit and inform our industry partners. As such, we\u2019ve curated a series of customer and industry spotlight articles that we found insightful. In this blog post, we share an article, sourced from MedTech Dive, titled \u201cFDA moving ahead with rulemaking on lab developed tests without waiting [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":68075,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[72],"tags":[841,844],"industry":[574],"class_list":["post-68074","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-development-and-management","tag-compliance-regulation","tag-jama-company-and-community-news","industry-medical-devices"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Makes Rules On Lab Developed Tests - Jama Software<\/title>\n<meta name=\"description\" content=\"This industry spotlights blog shares news on the FDA moving ahead with new rules on lab-developed tests without waiting for Congress.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202023-03-03%20MedTech%20Dive%20%5Bissue:48520%5D&utm_term=MedTech%20Dive\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld\" \/>\n<meta property=\"og:description\" content=\"This industry spotlights blog shares news on the FDA moving ahead with new rules on lab-developed tests without waiting for Congress.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Issue: 2023-03-03 MedTech Dive [issue:48520]&amp;utm_term=MedTech Dive\" \/>\n<meta property=\"og:site_name\" content=\"Jama Software\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T10:00:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-18T08:25:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.jamasoftware.com\/legacy\/media\/2023\/04\/BioWorld-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jama Software\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jama Software\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/blog\\\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\\\/\"},\"author\":{\"name\":\"Jama Software\",\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/#\\\/schema\\\/person\\\/59a942565a528aa5f56b240c9342fc7f\"},\"headline\":\"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld\",\"datePublished\":\"2023-04-26T10:00:59+00:00\",\"dateModified\":\"2024-01-18T08:25:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/blog\\\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\\\/\"},\"wordCount\":458,\"image\":{\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.jamasoftware.com\\\/media\\\/2023\\\/04\\\/BioWorld-1.png\",\"keywords\":[\"Compliance &amp; Regulation\",\"Jama Company and Community News\"],\"articleSection\":[\"Product Development &amp; Management\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/blog\\\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\\\/\",\"url\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive\",\"name\":\"FDA Makes Rules On Lab Developed Tests - Jama Software\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.jamasoftware.com\\\/media\\\/2023\\\/04\\\/BioWorld-1.png\",\"datePublished\":\"2023-04-26T10:00:59+00:00\",\"dateModified\":\"2024-01-18T08:25:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/#\\\/schema\\\/person\\\/59a942565a528aa5f56b240c9342fc7f\"},\"description\":\"This industry spotlights blog shares news on the FDA moving ahead with new rules on lab-developed tests without waiting for Congress.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage\",\"url\":\"https:\\\/\\\/www.jamasoftware.com\\\/media\\\/2023\\\/04\\\/BioWorld-1.png\",\"contentUrl\":\"https:\\\/\\\/www.jamasoftware.com\\\/media\\\/2023\\\/04\\\/BioWorld-1.png\",\"width\":1024,\"height\":512,\"caption\":\"FDA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.medtechdive.com\\\/news\\\/fda-rulemaking-lab-developed-tests-hillebrenner\\\/643972\\\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.jamasoftware.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/#website\",\"url\":\"https:\\\/\\\/www.jamasoftware.com\\\/\",\"name\":\"Jama Software\",\"description\":\"Jama Connect\u00ae #1 in Requirements Management\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.jamasoftware.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.jamasoftware.com\\\/#\\\/schema\\\/person\\\/59a942565a528aa5f56b240c9342fc7f\",\"name\":\"Jama Software\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6e1172c5d380b2a20a9e5b5a4c0fb4e38bc497dc27ce100567da29abe37001af?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6e1172c5d380b2a20a9e5b5a4c0fb4e38bc497dc27ce100567da29abe37001af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6e1172c5d380b2a20a9e5b5a4c0fb4e38bc497dc27ce100567da29abe37001af?s=96&d=mm&r=g\",\"caption\":\"Jama Software\"},\"description\":\"Subject matter experts from Jama Software provide guidance and best practices on requirements management, test management, compliance and regulation, risk management, and complex product and software development.\",\"url\":\"https:\\\/\\\/www.jamasoftware.com\\\/blog\\\/author\\\/jama-software\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Makes Rules On Lab Developed Tests - Jama Software","description":"This industry spotlights blog shares news on the FDA moving ahead with new rules on lab-developed tests without waiting for Congress.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue: 2023-03-03 MedTech Dive [issue:48520]&utm_term=MedTech Dive","og_locale":"en_US","og_type":"article","og_title":"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld","og_description":"This industry spotlights blog shares news on the FDA moving ahead with new rules on lab-developed tests without waiting for Congress.","og_url":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue: 2023-03-03 MedTech Dive [issue:48520]&utm_term=MedTech Dive","og_site_name":"Jama Software","article_published_time":"2023-04-26T10:00:59+00:00","article_modified_time":"2024-01-18T08:25:46+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/www.jamasoftware.com\/legacy\/media\/2023\/04\/BioWorld-1.png","type":"image\/png"}],"author":"Jama Software","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jama Software","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#article","isPartOf":{"@id":"https:\/\/www.jamasoftware.com\/blog\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\/"},"author":{"name":"Jama Software","@id":"https:\/\/www.jamasoftware.com\/#\/schema\/person\/59a942565a528aa5f56b240c9342fc7f"},"headline":"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld","datePublished":"2023-04-26T10:00:59+00:00","dateModified":"2024-01-18T08:25:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.jamasoftware.com\/blog\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\/"},"wordCount":458,"image":{"@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage"},"thumbnailUrl":"https:\/\/www.jamasoftware.com\/media\/2023\/04\/BioWorld-1.png","keywords":["Compliance &amp; Regulation","Jama Company and Community News"],"articleSection":["Product Development &amp; Management"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.jamasoftware.com\/blog\/fda-moving-ahead-with-rulemaking-on-lab-devloped-tests-without-waiting-for-congress-bioworld\/","url":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive","name":"FDA Makes Rules On Lab Developed Tests - Jama Software","isPartOf":{"@id":"https:\/\/www.jamasoftware.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage"},"image":{"@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage"},"thumbnailUrl":"https:\/\/www.jamasoftware.com\/media\/2023\/04\/BioWorld-1.png","datePublished":"2023-04-26T10:00:59+00:00","dateModified":"2024-01-18T08:25:46+00:00","author":{"@id":"https:\/\/www.jamasoftware.com\/#\/schema\/person\/59a942565a528aa5f56b240c9342fc7f"},"description":"This industry spotlights blog shares news on the FDA moving ahead with new rules on lab-developed tests without waiting for Congress.","breadcrumb":{"@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#primaryimage","url":"https:\/\/www.jamasoftware.com\/media\/2023\/04\/BioWorld-1.png","contentUrl":"https:\/\/www.jamasoftware.com\/media\/2023\/04\/BioWorld-1.png","width":1024,"height":512,"caption":"FDA"},{"@type":"BreadcrumbList","@id":"https:\/\/www.medtechdive.com\/news\/fda-rulemaking-lab-developed-tests-hillebrenner\/643972\/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3a%202023-03-03%20MedTech%20Dive%20%5bissue%3a48520%5d&utm_term=MedTech%20Dive#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.jamasoftware.com\/"},{"@type":"ListItem","position":2,"name":"FDA Moving Ahead with Rulemaking On Lab Developed Tests Without Waiting for Congress: BioWorld"}]},{"@type":"WebSite","@id":"https:\/\/www.jamasoftware.com\/#website","url":"https:\/\/www.jamasoftware.com\/","name":"Jama Software","description":"Jama Connect\u00ae #1 in Requirements Management","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.jamasoftware.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.jamasoftware.com\/#\/schema\/person\/59a942565a528aa5f56b240c9342fc7f","name":"Jama Software","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6e1172c5d380b2a20a9e5b5a4c0fb4e38bc497dc27ce100567da29abe37001af?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6e1172c5d380b2a20a9e5b5a4c0fb4e38bc497dc27ce100567da29abe37001af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6e1172c5d380b2a20a9e5b5a4c0fb4e38bc497dc27ce100567da29abe37001af?s=96&d=mm&r=g","caption":"Jama Software"},"description":"Subject matter experts from Jama Software provide guidance and best practices on requirements management, test management, compliance and regulation, risk management, and complex product and software development.","url":"https:\/\/www.jamasoftware.com\/blog\/author\/jama-software\/"}]}},"_links":{"self":[{"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/posts\/68074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/comments?post=68074"}],"version-history":[{"count":0,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/posts\/68074\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/media\/68075"}],"wp:attachment":[{"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/media?parent=68074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/categories?post=68074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/tags?post=68074"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.jamasoftware.com\/legacy\/wp-json\/wp\/v2\/industry?post=68074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}